References
- Ben-Arye E, Attias S, Tadmor T, Schiff E. Herbs in hemato-oncological care: an evidence based review of data on efficacy, safety, and drug interactions. Leuk Lymphoma 2010;51: 1414–1423.
- Roberts H. Safety of herbal medicinal products in women with breast cancer Maturitas 2010 Mar 26. [Epub ahead of print].
- Rausch SM, Winegardner F, Kruk KM, et al. Complementary and alternative medicine: use and disclosure in radiation oncology community practice. Support Care Cancer 2010 Mar 25 [Epub ahead of print].
- Guzman G, Kallwitz ER, Wojewoda C, et al. Liver injury with features mimicking autoimmune hepatitis following the use of black cohosh. Case Report Med 2009;2009:918156.
- Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, Lewith GT. Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics 2010;125:768–776.
- Sewitch MJ, Rajput Y. A literature review of complementary and alternative medicine use by colorectal cancer patients. Complement Ther Clin Pract 2010;16:52–56.
- Stubblefield MD, Burstein HJ, Burton AW, et al. NCCN task force report: management of neuropathy in cancer. J Natl Compr Canc Netw 2009;7(Suppl. 5):S1–S26; quiz S27–28.
- Zhou Y, Garcia MK, Chang DZ, et al. Multiple myeloma, painful neuropathy, acupuncture? Am J Clin Oncol 2009;32:319–325.
- Argyriou AA, Iconomou G, Kalofonos HP. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood 2008;112:1593–1599.
- Longo CJ, Deber R, Fitch M, Williams AP, D'Souza D. An examination of cancer patients' monthly ‘out-of-pocket’ costs in Ontario, Canada. Eur J Cancer Care (Engl) 2007;16:500–507.
- Alsawaf MA, Jatoi A. Shopping for nutrition-based complementary and alternative medicine on the internet: how much money might cancer patients be spending online? J Cancer Educ 2007;22:174–176.
- Herman PM, Craig BM, Caspi O. Is complementary and alternative medicine (CAM) cost-effective? A systematic review. BMC Complement Altern Med 2005;5:11.
- Levine MN. Conventional and complementary therapies: a tale of two research standards? J Clin Oncol 2010;28:1979–1981.
- Golden EB, Lam PY, Kardosh A, et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009;113:5927–5937.
- Wang Q, Li J, Gu J, et al. Potentiation of (−)-epigallocatechin-3-gallate-induced apoptosis by bortezomib in multiple myeloma cells. Acta Biochim Biophys Sin (Shanghai) 2009;41:1018–1026.
- Shanafelt TD, Call TG, Zent CS, et al. Phase I trial of daily oral polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncol 2009;27:3808–3814.